导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.93% | 702/1050 |
| 近一周 | -5.05% | 1070/1104 |
| 近一月 | 0.10% | 82/1102 |
| 近一季 | -0.66% | 275/1092 |
| 近半年 | -15.55% | 900/1070 |
| 近一年 | 23.59% | 199/1018 |
| 近两年 | 105.52% | 173/926 |
| 近三年 | 84.39% | 116/834 |
| 成立以来 | 474.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.97% 417/1070 |
-21.75% 1058/1101 |
- - |
- - |
| 2025 | 93.46% 17/1065 |
7.23% 270/1014 |
6.46% 217/1038 |
40.36% 187/1050 |
20.74% 5/1065 |
| 2024 | 10.21% 284/1011 |
17.02% 5/960 |
1.54% 214/983 |
5.18% 878/991 |
-11.81% 949/1011 |
| 2023 | -1.40% 124/952 |
5.39% 300/880 |
-6.01% 577/895 |
4.13% 5/915 |
-4.41% 441/952 |
| 2022 | -2.16% 26/867 |
-6.21% 45/773 |
8.44% 332/806 |
-1.88% 29/845 |
-1.96% 537/867 |
| 2021 | 11.04% 233/740 |
-0.10% 155/580 |
15.60% 225/659 |
4.25% 138/704 |
-7.77% 631/740 |
| 2020 | 75.36% 115/554 |
-13.94% 405/419 |
23.95% 210/466 |
23.91% 23/517 |
32.68% 32/554 |
| 2019 | 29.53% 290/410 |
10.02% 1053/1149 |
1.01% 238/1231 |
-0.61% 348/390 |
17.28% 27/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实资源精选股票A VS. 东吴新产业精选股票A(580008) |